IP Library › Granted Patent US 12,281,088
Granted Patent B2
US 12,281,088 · App. 17/435,262 · Granted Apr 22, 2025

Process for the synthesis of vortioxetine

Inventor: Lihua Zhou (Suzhou, CN)
Assignee: SUZHOU FUDE ZHAOFENG BIOCHEMICAL TECHNOLOGY CO., LTD
C07D295/096B01J31/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,281,088
App. No.
17/435,262
Granted
Apr 22, 2025
Kind
B2
Abstract

The present invention relates to a process for the synthesis of Vortioxetine (I) or a pharmaceutically acceptable salt thereof. This process is accomplished by using a catalytic system consisting of a copper salt and an organic ligand, which can promote the formation of both C—N and C—S bond in one-pot, giving rise to an efficient, simple and industrially viable synthetic route for Vortioxetine.

Claims (7)

1. A catalyst system, which comprises a copper catalyst and a ligand, and the ligand is formula (L1)

2. The catalyst system of claim 1 , wherein the copper catalyst is selected from CuI, CuCl, CuBr, CuzO, Cu(acac) 2 CuCl 2 , CuBr 2 , Cul 2 , Cu(OAc) 2 , Cu(OTf) 2 , Cu (ClO 4 ) 2 , and CuSO 4 .

3. A method for manufacturing Vortioxetine (I),

which comprises the reaction of 1,2-dihalobenzene, 2,4-dimethylbenzenethiol and piperazine in the presence of a base and the catalyst system according to claim 1

wherein X and Y are selected from the group consisting of —Cl, —Br, and —I.

4. The method of claim 3 , wherein the base is selected from TEA, DBU, DIPEA, KOH, K 2 CO 3 , NaOH, Na 2 CO 3 , Cs 2 CO 3 , CsOH, K 3 PO 4 , K 2 HPO 4 , Na 3 PO 4 , and Na 2 HPO 4 .

5. The method of claim 3 , wherein all the reactions are carried out in one-pot.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2021
From: ZHOU, LIHUA
To: SUZHOU FUDE ZHAOFENG BIOCHEMICAL TECHNOLOGY CO., LTD
Reel/Frame 057389/0434 →
Priority Claims (2)
CN 202010946679.9 · Sep 10, 2020 · national
CN 202010946680.1 · Sep 10, 2020 · national
Continuity (1)
Related Publication 20220251055A1 · Aug 11, 2022
References Cited (7)
US 7144884B2 · Ruhland et al. · 2006 [cited by applicant]
US 8476279B2 · Bang-Anderson · 2013 [cited by applicant]
CN 101472906A · 2009 [cited by applicant]
CN 103788020A · 2014 [cited by applicant]
CN 105339361A · 2016 [cited by applicant]
WO 2013102573A1 · 2013 [cited by applicant]
Monkowius et al, Synthesis, Characterisation and Ligand Properties of Novel Bi-1,2,3-triazole ligands, Eur. J. Inorg. Chem, 2007, 4597-4606 (Year: 2007). [cited by examiner]